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INTRODUCTION
Amyloidosis is a systemic disease that is characterized 
by the deposition of fibrillary proteins in different organs. 
Primary, secondary, and familial forms of amyloidosis are 
defined in the literature (1). The primary form is a plasma 
cell dyscrasia in which a light chain of an immunoglobulin 
is deposited. Secondary amyloidosis is due to chronic 
disease such as diabetes mellitus (DM), rheumatoid 
arthritis, and sarcoidosis. Amyloid is produced from serum 
amyloid A (SAA), which is a acute-phase protein (2). The 
familial form is a group of autosomal-dominant disease 
in which a mutant protein is produced (1). Although 
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amyloidosis frequently affects multiple organs, localized 
forms were also reported (1). The histopathological features 
of pancreatic amyloidosis have been well defined in the 
literature; however, radiologic findings were rarely reported. 
In this report we present imaging findings of a patient with 
primary amyloidosis of pancreatic islet cells.
CASE REPORT 
A 39-year-old female patient was admitted to hospital 
with epigastric pain which was lasting for two months. She 
had no remarkable history except for her mother having 
DM. Moreover, a physical examination revealed epigastric 
tenderness on palpation, and laboratory examinations 
revealed no important findings. Endoscopy revealed 
edematous and fragile papilla of Vater, and a polyp was 
seen on the 2nd part of duodenum. A biopsy yielded a 
hyperplastic polyp, and a biopsy from the papilla was 
performed due to the imaging findings on endoscopy with 
suspicion of an ampulla tumor; however, biopsy specimens 
yielded no malignant cell. 
Ultrasonography (US) of the patient showed a 95
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diffusely enlarged hypoechoic pancreas with punctate 
hyperechogenities representing calcifications (Fig. 
1A). There was no altered vascularization of pancreatic 
parenchyma on Doppler US. Computed tomography (CT) 
revealed a huge pancreas, which was enlarged diffusely 
with multiple calcifications and punctate hyperdensities. 
The pancreatic duct and peripancreatic fat tissue were 
normal. There was no inflammation sign (Fig. 1B, C). CT 
of the thorax did not yield an important feature in the 
mediastinum and lung parenchyma. On magnetic resonance 
imaging (MRI), a diffusely enlarged pancreas was seen as 
hypointense on both T1- and T2-weighted images (Fig. 
1D, E). There were hyperintense cystic nodules in pancreas 
parenchyma on T2-weighted images (Fig. 1E). After 
gadolinium administration, enhancement of the pancreas 
began in the early phase, and became more prominent 
at delayed images. Punctate nodular unenhanced areas 
in pancreas parenchyma were seen on delayed images. 
Since the patient’s history revealed no sign for chronic 
pancreatitis and amylase levels were normal, a trucut 
biopsy with an 18 G needle (Bard Biopsy Systems, Tempe, 
AZ) was performed. According to the histopathological 
results, the diagnosis was islet cell primary amyloidosis of 
the pancreas. Only islet cells in the islands of Langerhans 
were stained red with congo red ink. Exocrine cells of the 
pancreas were spared (Fig. 1F). Fibrosis across the islet cell 
islands accompanied amyloidosis. The diagnosis of primary 
amyloidosis was established due to a color change of 
amyloid deposits after permanganate administration, which 
is not seen in secondary amyloid deposits. An oral glucose 
tolerance test revealed impaired glucose tolerance with 
increased glucose levels (160 mg/dL) during the 2nd hour 
after oral glucose administration, which was attributed to 
impaired glucose tolerance. 
 
DISCUSSION
Imaging findings of amyloidosis in several organs 
represent a wide spectrum since they can vary due to the 
type of amyloidosis (primary or secondary) and the degree 
of involvement (3). Primary amyloidosis may affect visceral 
organs in the abdomen including the liver, spleen, pancreas, 
and kidneys. Also, mesentery and retroperitoneal space may 
be affected in amyloidosis (3). 
Pancreatic involvement of amyloidosis was described in 
the literature mainly with histopathological findings. Due 
to these reports, pancreatic amyloidosis can be seen as 
diffuse infiltration of exocrine and endocrine pancreas. The 
endocrine part of pancreas is a frequent site of involvement 
in secondary amyloidosis and this is mainly due to the 
presence of type 2 DM (4). 
Despite frequent reports about histopathologic findings 
of pancreatic amyloidosis, we could not find enough reports 
regarding imaging findings of pancreatic amyloidosis. 
Also, these reports did not state the infiltrated portion of 
the pancreas (endocrine or exocrine part) in amyloidosis. 
Among these reports, Garcia (5) reported that the pancreas 
was seen enlarged and hypoechoic; diffusely in amyloidosis. 
On CT, pancreas was seen as diffusely hypodense and 
accompanying calcifications seen two years later. We also 
observed multiple calcifications in the pancreas. Amyloid 
deposits were reported to have an affinity for calcium 
and focal, punctate calcifications have been described in 
different organs with amyloid deposits (3, 5, 6). 
In our case, US findings were compatible with previous 
reports (2, 5). Diffuse hypoechogenicity of the pancreas 
might be due to diffuse involvement of the pancreas. 
However, CT findings were interesting; we did not see any 
disease in our records, which may enlarge the pancreas as 
seen in this patient. Diffuse infiltration of the pancreatic 
parenchyma may be seen in lymphoma, but the presence 
of multiple calcification and lack of accompanying 
lymphadenopathies excluded this entity in the differential 
diagnosis (7). Auto-immune pancreatitis is another entity 
that must be included in the differential diagnosis of diffuse 
pancreatic enlargement and infiltration. However auto-
immune pancreatitis characteristically cause a hypodense 
rim around the pancreas (7). Also, increased amounts of Ig 
G4 is a strong indicator of autoimmune pancreatitis with 
appropriate imaging findings. CT findings of our patient did 
not show either hypodense rim around the pancreas nor 
other inflammatory changes. Also, calcification is rarely 
seen in auto-immune pancreatitis. Acute inflammatory 
pancreatitis also may be investigated on patients with 
diffuse enlargement of the pancreas. However, the absence 
of pancreatic duct dilatation and lack of peripancreatic fat 
obliteration excluded the diagnosis of acute pancreatitis, 
with normal amylase levels in our case. Another feature of 
this case was the point that amyloidosis may mimic the 
ampulla Vater tumor on endoscopy by disseminating from 
pancreas to the papilla. Cross sectional imaging is important 
in these situations in order to prevent misdiagnosis. 
Loss of hyperintense signal of pancreas parenchyma with 
primary amyloidosis on T1-weighted image was reported 96
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previously (5, 8). We observed same the same finding in our 
case (Fig. 1D). Decreased signal intensity on T1-weighted 
images may be seen in diffuse pancreatitis, diffuse 
involvement of pancreas in tuberculosis, as well as lymphoma 
and autoimmune pancreatitis. Inflammatory pancreatitis, 
pancreatic lymphoma, and autoimmune pancreatitis may 
be excluded in differential diagnosis according to other 
imaging findings mentioned above. Increased signal 
Fig. 1. Imaging findings and histopathology of pancreatic amyloidosis.
A. Ultrasonography shows diffuse hypoechoic, enlarged pancreas including multiple millimetric calcifications with posterior acoustic enhancement 
(arrow). There is no pancreatic duct dilatation. B. Axial CT image shows diffuse prominent enlargement of pancreas (arrow), with multiple 
hyperdense calcifications (thin arrow). C. Axial CT after contrast enhancement on venous phase shows diffuse contrast enhancement of pancreas 
parenchyma with absence of inflammatory changes in peripancreratic tissues. D. Normal high signal intensity of pancreas is decreased on axial 
T1-weighted image. Pancreas is seen diffusely hypointense (arrow). E. Axial T2-weighted image of abdomen shows diffusely enlarged pancreas 
(arrow), with hyperintense cystic components (thin arrow). Pancreas tail is seen more hyperintense than body with no inflammation. Also, 
pancreatic duct is not dilated. F. Histopathologic examination reveals amyloid deposition stained with congo red islet cells of Langerhans (arrows). 
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intensity in pancreas and narrowing of pancreatic duct are 
seen in diffuse involvement of the pancreas in tuberculosis, 
which was absent in our case (9). 
We detected cystic lesions in pancreas parenchyma 
on T2-weighted images. We could not find any report 
indicating cystic changes in primary amyloidosis of 
pancreas and any other organ so cystic lesions are thought 
to occur incidentally. However, since imaging features of 
primary pancreas amyloidosis are rarely mentioned in the 
literature, we suggest that accompanying cystic lesions 
in pancreatic amyloidosis may be kept in mind. According 
to previous reports, increased signal intensity of the 
pancreas with amyloidosis was reported on T2-weighted 
images (5, 8). In our case, we observed a signal loss in 
the body and an increased signal in the pancreas tail. 
Our biopsy specimen was obtained from the body of the 
pancreas and histopathologic examination obtained after a 
revision request revealed fibrosis. Hence, we suggest that 
fibrosis may accompany amyloidosis and may cause focal 
decrease of signal intensity in the pancreas on T2-weighted 
images. This feature may explain heterogeneous contrast 
enhancement of the pancreas with amyloidosis described in 
the previous report (5). Decreased signal intensity of the 
pancreas on T1-weighted images is more reliable finding in 
the diagnosis. 
Though imaging methods and laboratory findings may 
suggest a diagnosis or exclude some diseases affecting 
pancreas histopathological confirmation of amyloidosis is 
necessary. In our case, only Langerhans island cells were 
affected from amyloidosis and exocrine pancreas did not 
show any amyloid infiltration. To the best of our knowledge, 
this is the first report that specifically describes imaging 
findings of islet cell amyloidosis. Previous reports described 
the pancreatic amyloidosis without discrimination of 
endocrine and exocrine pancreas amyloidosis. 
In our patient, the absence of other chronic disease 
findings and increased glucose levels at the oral glucose 
tolerance tests led us to think that amyloid deposition may 
induce DM. There was no romatologic or other systemic 
disease according to clinical investigations and laboratory 
findings as a cause of amyloidosis. It was shown that islet 
cell amyloidosis may be a cause of type 2 DM. Islet amyloid 
is present in > 90% of patients with type 2 DM. Recent 
data, particularly from transgenic mouse studies, indicate 
that islet amyloidosis is a diabetogenic factor, which is 
both a consequence (of insulin resistance) and cause (of 
beta-cell failure) of type 2 DM (10). Amyloid deposition, 
commonly seen in the pancreas of patients with type 2 DM, 
is generally classified as local amyloidosis and should not 
be confused with systemic involvement (4).
In conclusion, pancreatic amyloidosis may be included in 
the differential diagnosis of diffuse pancreatic enlargement 
mimicking pancreatitis. Absence of laboratory findings 
indicating acute pancreatitis, and abnormally enlarged 
pancreas may be seen in pancreatic amyloidosis. Imaging 
features of pancreatic amyloidosis on US, CT and MRI may 
alert radiologists and clinicians for the probability of DM 
development before prominent laboratory findings and 
clinical features. 
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